ISSN 2306-5559 (print)
ISSN 2410-938X (online)
ISSN 2410-938X (online)
The authors declare that there is no conflict of interest in this work.
1. Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah AS, McAllister DA, Gottlieb SL, Klug SJ, Winkler AS, Bray F. Estimates of the global burden of cervical cancer associated with HIV. The lancet global health. 2021 Feb 1;9(2):e161-9.2. Guida F, Kidman R, Ferlay J, at all. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022;28:2563–2572. DOI:10.1038/s41591-022-02109-2.3. Zhang YM, Jiang YH, Li HW, Li XZ, at.all. Purification and characterization of Lactobacillus plantarum-derived bacteriocin with activity against Staphylococcus argenteus planktonic cells and biofilm. J Food Sci. 2022;87(6):2718–2731. DOI:10.1111/1750-3841.16148.4. Mitra A, Kyrgiou M, Moscicki AB. Does the vaginal microbiota play a role in the development of cervical cancer? Transl Res. 2017;179:168–182. DOI:10.1016/j.trsl.2016.07.004.5. Diop K, Dufour JC, Levasseur A, Fenollar F. Exhaustive repertoire of human vaginal microbiota. Hum Microbiome J. 2019;11: DOI:10.1016/j.humic.2018.11.002.6. France MT, Ma B, Gajer P, Brown S, at all. VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition. Microbiome. 2020;8(1):166. DOI:10.1186/s40168-020-00934-6.7. Keburiya LK, Smolnikova VY, Priputnevich TV, Muravieva VV, at all. Does the uterine microbiota affect the reproductive outcomes in women with recurrent implantation failures?. BMC Womens Health. 2022;22:168. DOI:10.1186/s12905-022-01750-w.8. Darbandi A, Asadi A, Mahdizade Ari M, Ohadi E, at all. Bacteriocins: Properties and potential use as antimicrobials. J Clin Lab Anal. 2022;36(1):e24093. DOI:10.1002/jcla.24093.9. Asadi A, Lohrasbi V, Abdi M, Mirkalantari S, at all. The probiotic properties and potential of vaginal Lactobacillus spp. isolated from healthy women against some vaginal pathogens. Lett Appl Microbiol. 2022;74(5):752–764. DOI:10.1111/lam.13660.10. Witkin SS, Linhares IM. Why do lactobacilli dominate the human vaginal microbiota? BJOG. 2017;124(4):606–611. DOI:10.1113/1471-0528.14390.11. Gao H, Liu Q, Wang X, Li T, at all. Deciphering the role of female reproductive tract microbiome in reproductive health: a review. Front Cell Infect Microbiol. 2024;14:1351540. DOI:10.3389/fcimb.2024.1351540.12. Amabebe E, Anumba DOC.The vaginal microenvironment: The physiologic role of Lactobacilli. Front Med (Lausanne). 2018;5:181. DOI:10.3389/fmed.2018.00181.13. Wang Y, Thakur R, Shen Q, He Y, at all. Influences of vaginal microbiota on human papillomavirus infection and host immune regulation: What we have learned?Decoding Infect Transm. 2023;1:100002. DOI:10.1016/j.dcit.2023.07.001.14. Laniewski P, Barnes D, Goulder A, at all. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women. Sci Rep. 2018;8:7593.15. Pruski P, Lewis HV, Lee YS, и др.Assessment of microbiota:host interactions at the vaginal mucosa interface. Methods. 2018;149:74–84.16. Zhang Y, Wu X, Li D, Huang R, at all. HPV-associated cervicovaginal microbiome and host metabolome characteristics. BMC Microbiol. 2024;24(1):94. DOI:10.1186/s12866-024-03244-1.17. Smith SB, Ravel J. at all. The vaginal microbiota, host defence and reproductive physiology. J Physiol. 2017;595(2):451–463. DOI:10.1113/JP271694.18. Chen C, Xue J, Wang Y, Zhu X, at all. Effects of Th17 cells and IL-17 in the progression of cervical carcinogenesis with high-risk human papillomavirus infection. Cancer Med. 2018;7(2):297–306. DOI:10.1002/cam4.1279.19. Audirac-Chalifour A, Torres-Poveda K, Bahena-Román M, Téllez-Sosa J, at all. Cervical microbiome and cytokine profile at various stages of cervical cancer: a pilot study.PLoS One. 2016;11(4):e0153274. DOI:10.1371/journal.pone.0153274.20. Ntuli L, Mtshali A, Mzobe G, Liebenberg LJ, at all. Role of immunity and vaginal microbiome in clearance and persistence of human papillomavirus infection. Front Cell Infect Microbiol. 2022;12:927131. DOI:10.3389/fcimb.2022.927131.21. Dong M, Dong Y, Bai J, Li H, at all. Interactions between microbiota and cervical epithelial, immune, and mucus barrier. Front Cell Infect Microbiol. 2023;13:1124591. DOI:10.3389/fcimb.2023.1124591.22. Di Paola M, Sani C, Clemente AM, at all. Characterization of cervico-vaginal microbiota in women developing persistent high-risk human papillomavirus infection. Sci Rep. 2017;7:10200. DOI:10.1038/s41598-017-09842-6.23. Zhu M, Liu Y, Zhou Y, Mao T, at all. The relationship between menopausal syndrome and gut microbes. BMC Womens Health. 2022;22(1):437. DOI:10.1186/s12905-022-02029-w.24. Ghaniabadi R, Hashemi S, Bajgiran MS, Javadi S, Mohammadzadeh N, Masjedian F. Distribution of Lactobacillus species in Iranian women with both human papillomavirus (HPV) infection and bacterial vaginosis (BV). Meta Gene. 2020 Dec 1;26:100791.DOI:10.1016/j.mgene.2020.100791.25. Auriemma RS, Scairati R, Del Vecchio G, Liccardi A, at all. The vaginal microbiome: A long urogenital colonization throughout woman life. Front Cell Infect Microbiol. 2021;11:686167.26. Mei A, MacIntyre DA, Marchesi JR, Lee YS, at all. The vaginal microbiota, human papillomavirus infection and cervical intraepithelial neoplasia: what do we know and where are we going next? Microbiome. 2016;4(1):58. DOI:10.1186/s40168-016-0203-0.27. Kaur H, Merchant M, Haque MM, Mande SS. Crosstalk between female gonadal hormones and vaginal microbiota across various phases of women’s gynecological lifecycle. Front Microbiol. 2020;11: DOI:10.3389/fmicb.2020.00551.28. Głowienka-Stodolak M, Bagińska-Drabiuk K, Szubert S, Hennig EE, at all. Human papillomavirus infections and the role played by cervical and cervico-vaginal microbiota—Evidence from next-generation sequencing studies. Cancers. 2024;16(2):399. DOI:10.3390/cancers16020399.29. Mirmonsef P, Modur S, Burgad D, Gilbert D, at all. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause. 2015;22:702–709.30. Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42–50.31. Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221:9–18.e8. DOI:10.1016/j.ajog.2018.12.011.32. Li Y, Yu T, Yan H, Li D, at.all. Vaginal microbiota and HPV infection: Novel mechanistic insights and therapeutic strategies. Infect Drug Resist. 2020;13:1213–1220. DOI:10.2147/IDR.S210615.33. Sharifian K, Shoja Z, Jalilvand S.The interplay between human papillomavirus and vaginal microbiota in cervical cancer development. Virol J. 2023;20:73. DOI:10.1186/s12985-023-02037-8.34. Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, at all. Human papillomavirus infection and cervical cancer: Epidemiology, screening, and vaccination—Review of current perspectives. J Oncol. 2019;2019:3257939. DOI:10.1155/2019/3257939.35. Mei Z, Li D. The role of probiotics in vaginal health. Front Cell Infect Microbiol. 2022;12:963868. DOI:10.3389/fcimb.2022.963868.